Active in United Kingdom as both buyer and supplier — issued 81 contracts, and won 1 contract, most recently yesterday.
Top 5 suppliers won 95% of awarded value — £247.2m of £259m across 74 awards.
UKHSA seeks suppliers with lyophilisation expertise to develop freeze-drying services for inactivated pathogens to support pandemic preparedness and strategic resilience.
UKHSA seeks suppliers with lyophilisation expertise to freeze-dry irradiated pathogens for enhanced pandemic preparedness and diagnostic capability.
UKHSA is conducting market research to understand oligonucleotide manufacturing capabilities in the UK with the goal of strengthening domestic production for biosecurity and pandemic preparedness.
